The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Self-citationSunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Self-citationSorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa060655 · Cited by 4,802
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,647
Self-citationMotzer, R. J., Escudier, B., Oudard, S., Hutson, T. E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J. A., Figlin, R. A., Hollaender, N., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61039-9 · Cited by 3,019
Self-citationYang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Sternberg, C. N., Davis, I. D., Mardiak, J., Szczylik, C., Lee, E., Wagstaff, J., Barrios, C. H., Salman, P., Gladkov, O. A., Kavina, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.9764 · Cited by 2,471
Escudier, B., Pluzanska, A., Koralewski, P., Ravaud, A., Bracarda, S., Szczylik, C., Chevreau, C., Filipek, M., Melichar, B., Bajetta, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61904-7 · Cited by 2,217
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Oudard, S., Negrier, S., Szczylik, C., Pili, R., Bjarnason, G. A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1293 · Cited by 2,181
Self-citationHeng, D. Y. C., Xie, W., Regan, M. M., Warren, M. A., Golshayan, A. R., Sahi, C., Eigl, B. J., Ruether, J. D., Cheng, T., North, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4809 · Cited by 2,133
Self-citationPazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Cella, D., Reeves, J., Hawkins, R., Guo, J., Nathan, P., Staehler, M., de Souza, P., Merchan, J. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1303989 · Cited by 1,923
Self-citationRini, B. I., Escudier, B., Tomczak, P., Kaprin, A., Szczylik, C., Hutson, T. E., Michaelson, M. D., Gorbunova, V. A., Gore, M. E., Rusakov, I. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61613-9 · Cited by 1,840
Self-citationGuideline for Management of the Clinical T1 Renal Mass
Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H., Faraday, M. M., Kaouk, J. H., Leveillee, R. J., Matin, S. F., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.004 · Cited by 1,831
Self-citationFlanigan, R. C., Salmon, S. E., Blumenstein, B. A., Bearman, S. I., Roy, V., McGrath, P. C., Caton, J. R., Munshi, N., & Crawford, E. D. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003013 · Cited by 1,715
Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Wilding, G., Figlin, R. A., Ginsberg, M. S., Kim, S. T., Baum, C. M., DePrimo, S. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2574 · Cited by 1,634
Self-citationHuang, W. C., Levey, A. S., Serio, A. M., Snyder, M., Vickers, A. J., Raj, G. V., Scardino, P. T., & Russo, P. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70803-8 · Cited by 1,613
Motzer, R. J., Bacik, J., Murphy, B. A., Russo, P., & Mazumdar, M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.289 · Cited by 1,576
Self-citationCancer—Principles & Practice of Oncology
Rhoads, J. E. (1983) · PubMed Central · Cited by 1,466
Mickisch, G., Garin, A., van Poppel, H., de Prijck, L., & Sylvester, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06103-7 · Cited by 1,410
Fyfe, G., Fisher, R. I., Rosenberg, S. A., Sznol, M., Parkinson, D. R., & Louie, A. C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.688 · Cited by 1,391
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
Choueiri, T. K., Escudier, B., Powles, T., Mainwaring, P. N., Rini, B. I., Donskov, F., Hammers, H., Hutson, T. E., Lee, J.-L., Peltola, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510016 · Cited by 1,239
Self-citationSunitinib in Patients With Metastatic Renal Cell Carcinoma
Motzer, R. J., Rini, B. I., Bukowski, R. M., Curti, B. D., George, D. J., Hudes, G. R., Redman, B. G., Margolin, K. A., Merchan, J. R., Wilding, G., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2516 · Cited by 1,230
Self-citationFaivre, S., Delbaldo, C., Vera, K., Robert, C., Lozahic, S., Lassau, N., Bello, C., Deprimo, S., Brega, N., Massimini, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2194 · Cited by 1,164
Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma
Cheville, J. C., Lohse, C. M., Zincke, H., Weaver, A. L., & Blute, M. L. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200305000-00005 · Cited by 1,087
Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Staehler, M., Negrier, S., Chevreau, C., Desai, A. A., Rolland, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.5511 · Cited by 1,085
Heng, D. Y., Xie, W., Regan, M. M., Harshman, L. C., Bjarnason, G. A., Vaishampayan, U. N., Mackenzie, M., Wood, L., Donskov, F., Tan, M.-H., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70559-4 · Cited by 1,030
Self-citationNegrier, S., Escudier, B., Lasset, C., Douillard, J.-Y., Savary, J., Chevreau, C., Ravaud, A., Mercatello, A., Peny, J., Mousseau, M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381805 · Cited by 967
Choueiri, T. K., Escudier, B., Powles, T., Tannir, N. M., Mainwaring, P. N., Rini, B. I., Hammers, H. J., Donskov, F., Roth, B. J., Peltola, K., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30107-3 · Cited by 958
Self-citationMotzer, R. J., Hutson, T. E., Glen, H., Michaelson, M. D., Molina, A., Eisen, T., Jassem, J., Zolnierek, J., Maroto, J. P., Mellado, B., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00290-9 · Cited by 945
Self-citationAtkins, M. B., Hidalgo, M., Stadler, W. M., Logan, T. F., Dutcher, J. P., Hudes, G. R., Park, Y., Liou, S.-H., Marshall, B., Boni, J. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.185 · Cited by 942
Sunitinib: From Rational Design to Clinical Efficacy
Chow, L. Q. M., & Eckhardt, S. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.3602 · Cited by 883
Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis
FLANIGAN, R. C., MICKISCH, G., SYLVESTER, R., TANGEN, C., VAN POPPEL, H., & CRAWFORD, E. D. (2004) · Journal of Urology · doi:10.1097/01.ju.0000110610.61545.ae · Cited by 872
Strumberg, D., Richly, H., Hilger, R. A., Schleucher, N., Korfee, S., Tewes, M., Faghih, M., Brendel, E., Voliotis, D., Haase, C. G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.124 · Cited by 872
McDermott, D. F., Regan, M. M., Clark, J. I., Flaherty, L. E., Weiss, G. R., Logan, T. F., Kirkwood, J. M., Gordon, M. S., Sosman, J. A., Ernstoff, M. S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.206 · Cited by 820
Self-citationRandomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer
Yang, J. C., Sherry, R. M., Steinberg, S. M., Topalian, S. L., Schwartzentruber, D. J., Hwu, P., Seipp, C. A., Rogers-Freezer, L., Morton, K. E., White, D. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.122 · Cited by 790
Rini, B. I., Halabi, S., Rosenberg, J. E., Stadler, W. M., Vaena, D. A., Archer, L., Atkins, J. N., Picus, J., Czaykowski, P., Dutcher, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.5561 · Cited by 787
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A., Chertow, G., & Fan, D. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.10.020 · Cited by 773
Lau, W. K. O., Blute, M. L., Weaver, A. L., Torres, V. E., & Zincke, H. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.12.1236 · Cited by 755
Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience
Patard, J.-J., Leray, E., Rioux-Leclercq, N., Cindolo, L., Ficarra, V., Zisman, A., De La Taille, A., Tostain, J., Artibani, W., Abbou, C. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.055 · Cited by 754
Rosenberg, S. A., Mulé, J. J., Spiess, P. J., Reichert, C. M., & Schwarz, S. L. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.1169 · Cited by 745
Motzer, R. J., Escudier, B., Tomczak, P., Hutson, T. E., Michaelson, M. D., Negrier, S., Oudard, S., Gore, M. E., Tarazi, J., Hariharan, S., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70093-7 · Cited by 745
Self-citationThompson, R. H., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., Kwon, E. D., Cheville, J. C., & Blute, M. L. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.077 · Cited by 713
SURGICAL MANAGEMENT OF RENAL TUMORS 4 CM. OR LESS IN A CONTEMPORARY COHORT
LEE, C. T., KATZ, J., SHI, W., THALER, H. T., REUTER, V. E., & RUSSO, P. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67793-2 · Cited by 638
Haas, N. B., Manola, J., Uzzo, R. G., Flaherty, K. T., Wood, C. G., Kane, C., Jewett, M., Dutcher, J. P., Atkins, M. B., Pins, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00559-6 · Cited by 630
Self-citationSafety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
Gore, M. E., Szczylik, C., Porta, C., Bracarda, S., Bjarnason, G. A., Oudard, S., Hariharan, S., Lee, S.-H., Haanen, J., Castellano, D., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70162-7 · Cited by 589
LEIBOVICH, B. C., BLUTE, M. L., CHEVILLE, J. C., LOHSE, C. M., WEAVER, A. L., & ZINCKE, H. (2004) · Journal of Urology · doi:10.1097/01.ju.0000113274.40885.db · Cited by 581
Mekhail, T. M., Abou-Jawde, R. M., BouMerhi, G., Malhi, S., Wood, L., Elson, P., & Bukowski, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.179 · Cited by 559
Escudier, B., Szczylik, C., Hutson, T. E., Demkow, T., Staehler, M., Rolland, F., Negrier, S., Laferriere, N., Scheuring, U. J., Cella, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.3342 · Cited by 490
Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
Leibovich, B. C., Lohse, C. M., Crispen, P. L., Boorjian, S. A., Thompson, R. H., Blute, M. L., & Cheville, J. C. (2010) · The Journal of Urology · doi:10.1016/j.juro.2009.12.035 · Cited by 454
Luciani, L. G., Cestari, R., & Tallarigo, C. (2000) · Urology · doi:10.1016/s0090-4295(00)00534-3 · Cited by 452
Sternberg, C. N., Hawkins, R. E., Wagstaff, J., Salman, P., Mardiak, J., Barrios, C. H., Zarba, J. J., Gladkov, O. A., Lee, E., Szczylik, C., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.010 · Cited by 442
Blom, J. H. M., van Poppel, H., Maréchal, J., Didier Jacqmin, D., Schröder, F. H., de Prijck, L., & Sylvester, R. J. (2008) · European Urology · doi:10.1016/j.eururo.2008.09.052 · Cited by 436
Motzer, R. J., Barrios, C. H., Kim, T. M., Falcon, S., Cosgriff, T., Harker, W. G., Srimuninnimit, V., Pittman, K., Sabbatini, R., Rha, S. Y., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.6911 · Cited by 432
Self-citationNorton, E. C. (2012) · JAMA · doi:10.1001/jama.2012.475 · Cited by 417
Kim, S. P., Thompson, R. H., Boorjian, S. A., Weight, C. J., Han, L. C., Murad, M. H., Shippee, N. D., Erwin, P. J., Costello, B. A., Chow, G. K., et al. (2012) · Journal of Urology · doi:10.1016/j.juro.2012.03.006 · Cited by 408
Self-citationHutson, T. E., Lesovoy, V., Al-Shukri, S., Stus, V. P., Lipatov, O. N., Bair, A. H., Rosbrook, B., Chen, C., Kim, S., & Vogelzang, N. J. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70465-0 · Cited by 404
Hutson, T. E., Escudier, B., Esteban, E., Bjarnason, G. A., Lim, H. Y., Pittman, K. B., Senico, P., Niethammer, A., Lu, D. R., Hariharan, S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.3961 · Cited by 404
Self-citationEfficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma
Choueiri, T. K., Plantade, A., Elson, P. J., Négrier, S., Ravaud, A., Oudard, S. M., Zhou, M., Rini, B. I., Bukowski, R. M., & Escudier, B. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3223 · Cited by 393
Self-citation7-Year Oncological Outcomes After Laparoscopic and Open Partial Nephrectomy
Lane, B. R., & Gill, I. S. (2010) · Journal of Urology · doi:10.1016/j.juro.2009.10.023 · Cited by 346
Clark, J. W., Eder, J. P., Ryan, D., Lathia, C., & Lenz, H.-J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2658 · Cited by 342
Awada, A., Hendlisz, A., Gil, T., Bartholomeus, S., Mano, M., de Valeriola, D., Strumberg, D., Brendel, E., Haase, C. G., Schwartz, B., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602584 · Cited by 339
Moore, M., Hirte, H. W., Siu, L., Oza, A., Hotte, S. J., Petrenciuc, O., Cihon, F., Lathia, C., & Schwartz, B. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi310 · Cited by 305
Sengupta, S., Lohse, C. M., Leibovich, B. C., Frank, I., Thompson, R. H., Webster, W. S., Zincke, H., Blute, M. L., Cheville, J. C., & Kwon, E. D. (2005) · Cancer · doi:10.1002/cncr.21206 · Cited by 285
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib
Motzer, R. J., Hutson, T. E., McCann, L., Deen, K., & Choueiri, T. K. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1400731 · Cited by 271
Self-citationLane, B. R., Abouassaly, R., Gao, T., Weight, C. J., Hernandez, A. V., Larson, B. T., Kaouk, J. H., Gill, I. S., & Campbell, S. C. (2010) · Cancer · doi:10.1002/cncr.25184 · Cited by 260
Stadler, W. M., Figlin, R. A., McDermott, D. F., Dutcher, J. P., Knox, J. J., Miller, W. H., Hainsworth, J. D., Henderson, C., George, J. R., Hajdenberg, J. J., et al. (2010) · Cancer · doi:10.1002/cncr.24864 · Cited by 255
Choyke, P. L., Glenn, G. M., Walther, M. M., Zbar, B., & Linehan, W. M. (2003) · Radiology · doi:10.1148/radiol.2261011296 · Cited by 246
Rini, B. I., Melichar, B., Ueda, T., Grünwald, V., Fishman, M. N., Arranz, J. A., Bair, A. H., Pithavala, Y. K., Andrews, G. I., Pavlov, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70464-9 · Cited by 231
Self-citationShuch, B., Bratslavsky, G., Linehan, W. M., & Srinivasan, R. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0227 · Cited by 226
Self-citationPartial Versus Radical Nephrectomy for 4 to 7 cm Renal Cortical Tumors
Thompson, R. H., Siddiqui, S., Lohse, C. M., Leibovich, B. C., Russo, P., & Blute, M. L. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.08.087 · Cited by 224
FRANK, I., BLUTE, M. L., LEIBOVICH, B. C., CHEVILLE, J. C., LOHSE, C. M., & ZINCKE, H. (2005) · Journal of Urology · doi:10.1097/01.ju.0000158043.94525.d6 · Cited by 220
Uncommon and recently described renal carcinomas
Srigley, J. R., & Delahunt, B. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.70 · Cited by 209
The skeletal metastatic complications of renal cell carcinoma
Zekri, J., Ahmed, N., Coleman, R., & Hancock, B. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.2.379 · Cited by 204
Oudard, S., Banu, E., Vieillefond, A., Fournier, L., Priou, F., Medioni, J., Banu, A., Duclos, B., Rolland, F., Escudier, B., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.01.063 · Cited by 201
Shuch, B., Vourganti, S., Ricketts, C. J., Middleton, L., Peterson, J., Merino, M. J., Metwalli, A. R., Srinivasan, R., & Linehan, W. M. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.8192 · Cited by 200
Self-citationSequential therapy with sorafenib and sunitinib in renal cell carcinoma
Dudek, A. Z., Zolnierek, J., Dham, A., Lindgren, B. R., & Szczylik, C. (2009) · Cancer · doi:10.1002/cncr.24009 · Cited by 188
Weight, C. J., Lieser, G., Larson, B. T., Gao, T., Lane, B. R., Campbell, S. C., Gill, I. S., Novick, A. C., & Fergany, A. F. (2010) · European Urology · doi:10.1016/j.eururo.2010.04.033 · Cited by 188
Gore, M. E., Szczylik, C., Porta, C., Bracarda, S., Bjarnason, G. A., Oudard, S., Lee, S.-H., Haanen, J., Castellano, D., Vrdoljak, E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.196 · Cited by 187
Henry, D., Vadhan-Raj, S., Hirsh, V., von Moos, R., Hungria, V., Costa, L., Woll, P. J., Scagliotti, G., Smith, G., Feng, A., et al. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-013-2022-1 · Cited by 183
Lam, J. S., Shvarts, O., Said, J. W., Pantuck, A. J., Seligson, D. B., Aldridge, M. E., Bui, M. H. T., Liu, X., Horvath, S., Figlin, R. A., et al. (2005) · Cancer · doi:10.1002/cncr.21127 · Cited by 173
A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell Carcinoma
Tannir, N. M., Plimack, E., Ng, C., Tamboli, P., Bekele, N. B., Xiao, L., Smith, L., Lim, Z., Pagliaro, L., Araujo, J., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.06.043 · Cited by 164
Self-citationSequential Sorafenib and Sunitinib for Renal Cell Carcinoma
Sablin, M., Négrier, S., Ravaud, A., Oudard, S. M., Balleyguier, C., Gautier, J., Celier, C., Médioni, J., & Escudier, B. J. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.02.119 · Cited by 152
Zisman, A., Pantuck, A. J., Chao, D. H., DOREY, F. J., SAID, J. W., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66075-2 · Cited by 151
Weight, C., Larson, B. T., Gao, T., Campbell, S. C., Lane, B. R., Kaouk, J. H., Gill, I. S., Klein, E. A., & Fergany, A. F. (2010) · Urology · doi:10.1016/j.urology.2009.11.087 · Cited by 143
Beck, J., Procopio, G., Bajetta, E., Keilholz, U., Négrier, S., Szczylik, C. A., Bokemeyer, C., Sergio Bracarda, A., Richel, D. J., Staehler, M. D., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq651 · Cited by 135
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Lorenzo, G. D., Cartenì, G., Riccardo Autorino, B., Bruni, G., Tudini, M., Rizzo, M., Aieta, M., Gonnella, A., Rescigno, P., Perdonà, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6480 · Cited by 131
Motzer, R. J., Hutson, T. E., Ren, M., Dutcus, C. E., & Larkin, J. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00543-4 · Cited by 124
Self-citationSunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Gordon, M. S. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79179-x · Cited by 118
1. Sorafenib in advanced clear-cell renal-cell carcinoma
Trump, D. L. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.08.008 · Cited by 109
Renal medullary carcinoma: report of seven cases from Brazil
Watanabe, I. C., Billis, A., Guimarães, M. S., Alvarenga, M., de Matos, A. C., Cardinalli, I. A., Filippi, R. Z., de Castro, M. G., & Suzigan, S. (2007) · Modern Pathology · doi:10.1038/modpathol.3800934 · Cited by 104
Eichelberg, C., Heuer, R., Chun, F. K. ‐., Hinrichs, K., Zacharias, M., Huland, H., & Hans Heinzer, A. (2008) · European Urology · doi:10.1016/j.eururo.2008.07.051 · Cited by 100
Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience
Lam, J. S., Klatte, T., Patard, J., Goel, R. H., Guillé, F., Lobel, B., Abbou, C.-C. C., TAILLE, A. D. L., Tostain, J., Cindolo, L., et al. (2007) · European Urology · doi:10.1016/j.eururo.2007.01.106 · Cited by 100
Dall’Oglio, M. F., Ribeiro‐Filho, L. A., Antunes, A. A., Crippa, A., Nesrallah, L., Gonçalves, P. D., Leite, K. R. M., & Srougi, M. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.128 · Cited by 95
Ficarra, V., Schips, L., Guillé, F., Li, G., TAILLE, A. D. L., Galetti, T. P., Cindolo, L., Novara, G., Zigeuner, R. E., Bratti, E., et al. (2005) · Cancer · doi:10.1002/cncr.21254 · Cited by 93
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
Molina, A. M., Feldman, D. R., Ginsberg, M. S., Kroog, G. S., Tickoo, S. K., Jia, X., Georges, M., Patil, S., Baum, M. S., Reuter, V. E., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9491-6 · Cited by 87
Self-citationAxitinib for renal cell carcinoma
Sonpavde, G., Hutson, T. E., & Rini, B. I. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.5.741 · Cited by 83
Self-citationDutcher, J. P., Fisher, R. I., Weiss, G. R., Aronson, F. R., Margolin, K. A., Louie, A. C., Mier, J. W., Caliendo, G., Sosman, J. A., Eckardt, J. R., et al. (1997) · PubMed · Cited by 78
Self-citationMichaelson, M. D., McKay, R. R., Werner, L. L., Atkins, M. B., Allen, E. M. V., Olivier, K. M., Song, J., Signoretti, S., McDermott, D. F., & Choueiri, T. K. (2015) · Cancer · doi:10.1002/cncr.29503 · Cited by 76
Self-citationPrognostic Impact of Tumor Size on pT2 Renal Cell Carcinoma: An International Multicenter Experience
Klatte, T., Patard, J., Goel, R. H., Kleid, M. D., Guillé, F., Lobel, B., Abbou, C.-C. C., TAILLE, A. D. L., Tostain, J., Cindolo, L., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.046 · Cited by 67
Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor
Dall’Oglio, M. F., Antunes, A. A., Sarkis, A. S., Crippa, A., Leite, K. R. M., Lucón, A. M., & Srougi, M. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07015.x · Cited by 66
Hunter, G. K., Balagamwala, E. H., Koyfman, S. A., Bledsoe, T. B., Sheplan, L. J., Reddy, C. A., Chao, S. T., Djemil, T., Angelov, L., & Videtic, G. M. M. (2012) · Practical Radiation Oncology · doi:10.1016/j.prro.2012.01.005 · Cited by 55
Metastatic renal cell carcinoma: Results of a population-based study with 25 years follow-up
Schlesinger‐Raab, A., Treiber, U., Zaak, D., Hölzel, D., & Engel, J. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.039 · Cited by 40
Matrana, M. R., Duran, C., Shetty, A., Xiao, L., Atkinson, B. J., Corn, P. G., Pagliaro, L. C., Millikan, R. E., Charnsangave, C., Jonasch, E. W., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.003 · Cited by 38
Self-citationVincenzi, B., Santini, D., Cesa, A. L., & Tonini, G. (2004) · Cancer · doi:10.1002/cncr.20194 · Cited by 11
Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience
Blute, M. L. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.11.016 · Cited by 5
Ficarra, V., Schips, L., Guillé, F., Li, G., TAILLE, A. D. L., Galetti, T. P., Cindolo, L., Novara, G., Zigeuner, R. E., Bratti, E., et al. (2005) · European Urology Supplements · doi:10.1016/s1569-9056(05)80045-4 · Cited by 4
Cited by
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Self-citationTannir, N. M., Jonasch, E., Albiges, L., Altinmakas, E., Ng, C. S., Matin, S. F., Wang, X., Qiao, W., Dubauskas Lim, Z., Tamboli, P., et al. (2016) · European Urology · doi:10.1016/j.eururo.2015.10.049 · Cited by 364
Self-citationManagement of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
Rathmell, W. K., Rumble, R. B., Van Veldhuizen, P. J., Al-Ahmadie, H., Emamekhoo, H., Hauke, R. J., Louie, A. V., Milowsky, M. I., Molina, A. M., Rose, T. L., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00868 · Cited by 336
Lalani, A.-K. A., Xie, W., Martini, D. J., Steinharter, J. A., Norton, C. K., Krajewski, K. M., Duquette, A., Bossé, D., Bellmunt, J., Van Allen, E. M., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0315-0 · Cited by 270
Self-citationVan Cutsem, E., Martinelli, E., Cascinu, S., Sobrero, A., Banzi, M., Seitz, J.-F., Barone, C., Ychou, M., Peeters, M., Brenner, B., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0072 · Cited by 142
Metadata
- Authors
- Motzer, R. J., Jonasch, E., Agarwal, N., Bhayani, S., Bro, W. P., Chang, S. S., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Fishman, M., Gallagher, T. H., Gore, J. L., Hancock, S. L., Harrison, M. R., Kim, W., Kyriakopoulos, C., LaGrange, C., Lam, E. T., Lau, C., Michaelson, M. D., Olencki, T., Pierorazio, P. M., Plimack, E. R., Redman, B. G., Shuch, B., Somer, B., Sonpavde, G., Sosman, J., Dwyer, M., & Kumar, R.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2017-06
- Volume
- 15
- Issue
- 6
- Pages
- 804-834
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2792333466
- Cited by
- 571
- References
- 108
- FWCI
- 65.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.